ID   RD/18
AC   CVCL_IU87
SY   RD18
DR   Cosmic; 1082514
DR   Wikidata; Q54949541
RX   PubMed=1917385;
RX   PubMed=8617485;
CC   Sequence variation: Homozygous for NRAS p.Gln61His (c.183A>T) (from parent cell line).
CC   Sequence variation: Homozygous for TP53 p.Arg248Trp (c.742C>T) (from parent cell line).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 12-03-20; Version: 4
//
RX   PubMed=1917385;
RA   Lollini P.-L., De Giovanni C., Landuzzi L., Nicoletti G., Scotlandi K.,
RA   Nanni P.;
RT   "Reduced metastatic ability of in vitro differentiated human
RT   rhabdomyosarcoma cells.";
RL   Invasion Metastasis 11:116-124(1991).
//
RX   PubMed=8617485; DOI=10.1016/S0046-8177(96)90115-X;
RA   Scotlandi K., Serra M., Manara M.C., Benini S., Sarti M., Maurici D.,
RA   Lollini P.-L., Picci P., Bertoni F., Baldini N.;
RT   "Immunostaining of the p30/32MIC2 antigen and molecular detection of
RT   EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral
RT   neuroectodermal tumor.";
RL   Hum. Pathol. 27:408-416(1996).
//